G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillPodcast
![]() |
Hear G. Steven Burrill's vision of healthcare in the year 2020 in a special podcast from The Journal of Life Sciences. |
Burrill Conferences
Life Sciences Conferences
The Burrill India Life Sciences Meeting
AgendaPreliminary Agenda
June 16, 2008
7:30 a.m. – 8:00 a.m.
Breakfast & Registration
8:00 a.m. – 8:45 a.m.
Keynote Presentation:
G. Steven Burrill, CEO, Burrill & Company
8:45 a.m. – 9:00 a.m.
China / San Diego / California - Global Biotech Cluster
Joe Panetta, President & CEO, BIOCOM
9:00 a.m. -9:15 a.m
Break
9:15 a.m. – 10:30 a.m.
The Life Science Revolution in
• Areas of Innovation that
- Rashmi Barbhaiya, PhD, CEO & Managing Director, Advinus Therapeutics
- Ajit Singh, PhD, CEO, Siemens Healthcare, Image & Knowledge
Management Group
• Reaching Beyond: From Domestic to International Markets
- Arun Chandavarkar, PhD, COO, Biocon
- Greg Wiederrecht, PhD, VP External Scientific Affairs, Merck
• Creating Value in a Global Marketplace
- Sreeni Devidas, PhD VP, Business Development, GVK BioSciences
- Dr. Swati Piramal, Director, Strategic Alliances & Communications, Nicholas
Piramal India Ltd
Moderated by: Tania Fernandez, PhD, Director India, Burrill & Comapny
10:30 a.m – 11:45 a.m.
Models of Global Growth by Leading Indian Companies
• Expansion into US Specialty Therapeutics
- Jeffrey Wasserstein, EVP, North America Specialty, Dr. Reddy’s
Laboratories
• Leadership in Global Generics through Regional Expansion
- Shyam Bishen, PhD, VP, Corporate Development, Ranbaxy Pharmaceuticals
• Transitioning from Services to Proprietary Drug Development
- Venkat Jasti, Vice Chairman & CEO, Suven Life Sciences
• Vertical Integration Via M&A
- Sridhar Mosur, President & CEO, Jubilant Discovery Services &
Jubilant Biosys
• Growth Through Strategic Partnerships
- Andres Liivak, Partner, Reed Smith
Moderated by: Mohan Iyer, Managing Director, Merchant Banking Group, Burrill
& Company
11:45 a.m. – 12:45 p.m.
Networking Lunch
12:45 p.m. – 2:00 p.m.
Capital Markets in
• Where is the Capital Coming From?
- Anna Lavelle, PhD, CEO & Executive Director, AusBiotech
- Robert Power, VP, Investment Banking, NYSE Euronext
- Villoo Morawalla Pate, PhD, Founder and Managing Director of Avestha
Gengraine Technologies
• How Can You Build Value in Indian Life Science Companies?
- Dr. Anula Jayasuriya, PhD, Managing Director, Evolvence
Fund
2:00 p.m. – 2:45 p.m.
Shining examples of Indian life science companies on the horizon
- Advinus (Pharma): Kasim Mookhtiar, PhD, CSO & SVP
- Chembiotek- A TCG Lifesciences Co. (Discovery Services): Ashis Saha, PhD, VP, Discovery
- MetaHelix Life Sciences (Agbio): Dr. Vasudera Rao, President, Agriculture Technologies
- Ocimum Biosolutions (Services): Anuradha Acharya, CEO
Moderated by: Ganesh Kishore, PhD, Managing Director, Burrill & Company
2:45 p.m. – 3:00 p.m.
Break
3:00 p.m. – 3:45 p.m.
Year 2020 – China/India: A Comparison
• Futurist who can find what
Rashmi Barbhaiya, PhD, CEO & Managing Director, Advinus Therapeutics
• Futurist who can find what
Hongguang Wang,PhD, Director General,
Biotechnology
Moderated by: G. Steven Burrill, CEO, Burrill & Company
3:45 p.m. – 4:00 p.m.
Closing Remarks
G. Steven Burrill, CEO, Burrill & Company
4:00 p.m. – 5:30 p.m.
Networking Reception
Sponsored by: Wilson Sonsini Goodrich & Rosati


.jpg)